What to expect when you take Terazosin hydrochloride and have Diabetes - type 2?

Do you take Terazosin hydrochloride and have Diabetes - type 2? Find out below what new side effects and undetected conditions people who are 50-59 years old may have. This prediction is created after we perform predictive analysis on health care big data. It will be updated regularly.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and monitor them (see testimonials). If you find eHealthMe useful, please help us to spread the words below or leave us a testimonial.



On Nov, 19, 2018

1,683 reports have been studied.


Females aged 50 to 59 :

289 related reports were analyzed:

Most common symptoms:

Abdominal pain upper
  • 9.0% for females aged 50 (±5) who take Terazosin hydrochloride
Abscess
  • 5.54% for females aged 50 (±5) who take Terazosin hydrochloride
Acute kidney failure
  • 5.19% for females aged 50 (±5) who take Terazosin hydrochloride
Anhedonia
  • 9.69% for females aged 50 (±5) who take Terazosin hydrochloride
Arrhythmias
  • 5.88% for females aged 50 (±5) who take Terazosin hydrochloride
Back pain
  • 5.54% for females aged 50 (±5) who take Terazosin hydrochloride
Bone disorder
  • 6.57% for females aged 50 (±5) who take Terazosin hydrochloride
Bronchopleural fistula
  • 5.54% for females aged 50 (±5) who take Terazosin hydrochloride
Cerebrovascular disorder
  • 6.23% for females aged 50 (±5) who take Terazosin hydrochloride
Cervical spinal stenosis
  • 5.88% for females aged 50 (±5) who take Terazosin hydrochloride
Chest pain
  • 13.84% for females aged 50 (±5) who take Terazosin hydrochloride
Chronic fatigue syndrome
  • 5.19% for females aged 50 (±5) who take Terazosin hydrochloride
Constipation
  • 5.19% for females aged 50 (±5) who take Terazosin hydrochloride
Cough
  • 10.03% for females aged 50 (±5) who take Terazosin hydrochloride
Cyst
  • 5.88% for females aged 50 (±5) who take Terazosin hydrochloride
Depression
  • 12.11% for females aged 50 (±5) who take Terazosin hydrochloride
Diarrhea
  • 11.07% for females aged 50 (±5) who take Terazosin hydrochloride
Dizziness
  • 6.23% for females aged 50 (±5) who take Terazosin hydrochloride
Drowsiness
  • 7.27% for females aged 50 (±5) who take Terazosin hydrochloride
Dyspnea
  • 7.96% for females aged 50 (±5) who take Terazosin hydrochloride
Emphysema
  • 5.54% for females aged 50 (±5) who take Terazosin hydrochloride
Empyema
  • 5.54% for females aged 50 (±5) who take Terazosin hydrochloride
Endocarditis
  • 5.19% for females aged 50 (±5) who take Terazosin hydrochloride
Enlarged heart
  • 7.96% for females aged 50 (±5) who take Terazosin hydrochloride
Eye discharge
  • 5.54% for females aged 50 (±5) who take Terazosin hydrochloride
Faecal incontinence
  • 5.88% for females aged 50 (±5) who take Terazosin hydrochloride
Fall
  • 12.11% for females aged 50 (±5) who take Terazosin hydrochloride
Fatigue
  • 9.34% for females aged 50 (±5) who take Terazosin hydrochloride
Fever
  • 9.34% for females aged 50 (±5) who take Terazosin hydrochloride
Fibula fracture
  • 5.88% for females aged 50 (±5) who take Terazosin hydrochloride
Foot deformity
  • 5.54% for females aged 50 (±5) who take Terazosin hydrochloride
Foot fracture
  • 5.88% for females aged 50 (±5) who take Terazosin hydrochloride
Gait disturbance
  • 5.88% for females aged 50 (±5) who take Terazosin hydrochloride
Gastritis
  • 10.03% for females aged 50 (±5) who take Terazosin hydrochloride
Gastroesophageal reflux disease
  • 10.03% for females aged 50 (±5) who take Terazosin hydrochloride
Generalized anxiety disorder
  • 5.19% for females aged 50 (±5) who take Terazosin hydrochloride
Headache
  • 6.57% for females aged 50 (±5) who take Terazosin hydrochloride
High blood pressure
  • 11.42% for females aged 50 (±5) who take Terazosin hydrochloride
Hydropneumothorax
  • 5.19% for females aged 50 (±5) who take Terazosin hydrochloride
Hypoacusis
  • 5.19% for females aged 50 (±5) who take Terazosin hydrochloride
Injury
  • 7.96% for females aged 50 (±5) who take Terazosin hydrochloride
Injury corneal
  • 5.54% for females aged 50 (±5) who take Terazosin hydrochloride
Insomnia
  • 6.23% for females aged 50 (±5) who take Terazosin hydrochloride
Irritable bowel syndrome
  • 6.57% for females aged 50 (±5) who take Terazosin hydrochloride
Itching
  • 5.19% for females aged 50 (±5) who take Terazosin hydrochloride
Joint pain
  • 5.88% for females aged 50 (±5) who take Terazosin hydrochloride
Lip and/or oral cavity cancer
  • 5.54% for females aged 50 (±5) who take Terazosin hydrochloride
Lip discoloration
  • 5.54% for females aged 50 (±5) who take Terazosin hydrochloride
Lung infection
  • 5.19% for females aged 50 (±5) who take Terazosin hydrochloride
Mastication disorder
  • 5.54% for females aged 50 (±5) who take Terazosin hydrochloride
Menopause
  • 5.19% for females aged 50 (±5) who take Terazosin hydrochloride
Migraine with aura
  • 5.19% for females aged 50 (±5) who take Terazosin hydrochloride
Nausea
  • 13.15% for females aged 50 (±5) who take Terazosin hydrochloride
Neuropathy peripheral
  • 6.57% for females aged 50 (±5) who take Terazosin hydrochloride
Oedema peripheral
  • 18.34% for females aged 50 (±5) who take Terazosin hydrochloride
Oropharyngeal pain
  • 5.54% for females aged 50 (±5) who take Terazosin hydrochloride
Osteoarthritis
  • 6.57% for females aged 50 (±5) who take Terazosin hydrochloride
Osteonecrosis of jaw
  • 7.27% for females aged 50 (±5) who take Terazosin hydrochloride
Osteopenia
  • 5.19% for females aged 50 (±5) who take Terazosin hydrochloride
Osteoporosis
  • 5.88% for females aged 50 (±5) who take Terazosin hydrochloride
Osteoradionecrosis
  • 5.54% for females aged 50 (±5) who take Terazosin hydrochloride
Pain
  • 13.84% for females aged 50 (±5) who take Terazosin hydrochloride
Pain in extremity
  • 8.65% for females aged 50 (±5) who take Terazosin hydrochloride
Pain in jaw
  • 6.92% for females aged 50 (±5) who take Terazosin hydrochloride
Panic disorder
  • 5.19% for females aged 50 (±5) who take Terazosin hydrochloride
Rashes
  • 11.42% for females aged 50 (±5) who take Terazosin hydrochloride
Renal failure acute
  • 6.57% for females aged 50 (±5) who take Terazosin hydrochloride
Retching
  • 9.69% for females aged 50 (±5) who take Terazosin hydrochloride
Rib fracture
  • 5.54% for females aged 50 (±5) who take Terazosin hydrochloride
Rotator cuff syndrome
  • 5.54% for females aged 50 (±5) who take Terazosin hydrochloride
Sinusitis
  • 7.96% for females aged 50 (±5) who take Terazosin hydrochloride
Sleep apnea syndrome
  • 5.19% for females aged 50 (±5) who take Terazosin hydrochloride
Spinal osteoarthritis
  • 7.61% for females aged 50 (±5) who take Terazosin hydrochloride
Stress and anxiety
  • 13.49% for females aged 50 (±5) who take Terazosin hydrochloride
Tibia fracture
  • 5.54% for females aged 50 (±5) who take Terazosin hydrochloride
Tooth disorder
  • 9.69% for females aged 50 (±5) who take Terazosin hydrochloride
Tooth fracture
  • 9.34% for females aged 50 (±5) who take Terazosin hydrochloride
Toothaches
  • 5.19% for females aged 50 (±5) who take Terazosin hydrochloride
Transient ischaemic attack
  • 8.3% for females aged 50 (±5) who take Terazosin hydrochloride
Urinary incontinence
  • 6.23% for females aged 50 (±5) who take Terazosin hydrochloride
Vision blurred
  • 5.54% for females aged 50 (±5) who take Terazosin hydrochloride
Weakness
  • 10.73% for females aged 50 (±5) who take Terazosin hydrochloride
Wound infection staphylococcal
  • 5.19% for females aged 50 (±5) who take Terazosin hydrochloride

Most common co-existing conditions:

Arthritis
  • 6.92% for females aged 50 (±5) who take Terazosin hydrochloride
Bone density abnormal
  • 5.19% for females aged 50 (±5) who take Terazosin hydrochloride
Diabetes
  • 5.88% for females aged 50 (±5) who take Terazosin hydrochloride
Gastroesophageal reflux disease
  • 6.23% for females aged 50 (±5) who take Terazosin hydrochloride
Hormone replacement therapy
  • 5.54% for females aged 50 (±5) who take Terazosin hydrochloride
Multiple sclerosis
  • 8.3% for females aged 50 (±5) who take Terazosin hydrochloride
back to top

Males aged 50 to 59 :

1,394 related reports were analyzed:

Most common symptoms:

Chest pain
  • 5.16% for males aged 50 (±5) who take Terazosin hydrochloride
Dizziness
  • 5.09% for males aged 50 (±5) who take Terazosin hydrochloride
Fatigue
  • 6.31% for males aged 50 (±5) who take Terazosin hydrochloride
Hypotension
  • 5.88% for males aged 50 (±5) who take Terazosin hydrochloride
Nausea
  • 6.38% for males aged 50 (±5) who take Terazosin hydrochloride
Pain
  • 5.16% for males aged 50 (±5) who take Terazosin hydrochloride
Weakness
  • 8.25% for males aged 50 (±5) who take Terazosin hydrochloride

Most common co-existing conditions:

High blood cholesterol
  • 5.38% for males aged 50 (±5) who take Terazosin hydrochloride
back to top

Do you take Terazosin hydrochloride and have Diabetes - type 2:

  • To personalize this prediction to you, including to your gender, age, personal and family history, and more: Click here

Related studies

terazosin hydrochloride

Terazosin hydrochloride has active ingredients of terazosin hydrochloride. It is often used in prostate examination abnormal. (latest outcomes from Terazosin hydrochloride 1,655 users)

diabetes - type 2

Diabetes - type 2 has been reported by people with high blood cholesterol, low density lipoprotein increased, depression, bipolar disorder (latest reports from 233,995 Diabetes - type 2 patients).

General study

Recent updates

Recent general studies
Recent personal studies

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on ePatient.care is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the ePatient.care site and its content is at your own risk.

Submit your testimonial

  • Please fill in your Testimonial.
  • Please enter a minimum of 10 characters for your Testimonial.
  • Please fill in your Name.

Please wait...

{progressItem}

Thank you!